• HSD112 Can Risk Management Practices Foster the Role of Big Data and Data Analytics in Improving the Quality of Healthcare Services? Evidence From a Survey Among Healthcare Professionals

    Dec 1, 2022, 00:00

  • PCR190 Health-Related Quality of Life Outcomes of Very Preterm or Very Low Birth Weight Adults: Evidence From an Individual Participant Data Meta-Analysis

    Dec 1, 2022, 00:00

  • EPH161 Public Health Impact and Cost-Effectiveness Analysis of Universal Varicella Vaccination in the United Kingdom

    Dec 1, 2022, 00:00

  • EE216 Expenditure on Medicines for the Treatment of Multiple Myeloma in Catalonia for 2021

    Dec 1, 2022, 00:00

  • MT16 Jumping Through Hoops: Critical Considerations on Current Draft Reimbursement Guidance for Medical Devices

    Dec 1, 2022, 00:00

  • EPH41 Evaluating Population Health Priorities for Community Health Workers

    Dec 1, 2022, 00:00

  • HSD65 Portuguese Clinical Practice in the Treatment of Advanced Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations

    Dec 1, 2022, 00:00

  • HTA132 Suitability of Value-Based Price Forecasting in a Crowded Landscape: A Case Study in Rheumatoid Arthritis

    Dec 1, 2022, 00:00

  • RWD123 Real-World Data About Treatment Pattern and Outcomes of Patients With Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma in Fran Results From the Fregat Database

    Dec 1, 2022, 00:00

  • EE666 Cost-Analysis of the Introduction of a Second Generation Biomarker Breast Cancer Prognostic Test for the Management of Early Breast Cancer in Greece

    Dec 1, 2022, 00:00

  • PCR64 Patient Satisfaction With 6-Monthly Versus 3-Monthly Paliperidone Palmitate Long-Acting Injectable for Schizophrenia Treatment: Results From a Phase-3, Randomised, Noninferiority Study

    Dec 1, 2022, 00:00

  • EE106 Cost-Effectiveness Analysis of Bimekizumab in Patients With Moderate-to-Severe Plaque Psoriasis in Greece

    Dec 1, 2022, 00:00

  • CO85 Evidence Gap Analysis of the Burden of Illness and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

    Dec 1, 2022, 00:00

  • EE249 Incorporating Litigation Costs in Economic Evaluation

    Dec 1, 2022, 00:00

  • HPR16 Comparison of Outcomes-Based Reimbursement (OBR) Schemes in Europe and the US for CAR-T Cell Therapy: Tisagenlecleucel

    Dec 1, 2022, 00:00

  • P10 Modelling Spillover Effects on Informal Carers: The 'Carer QALY Trap'

    Dec 1, 2022, 00:00

  • RWD162 Rationale of Level-Funded Health Plans for Women in US

    Dec 1, 2022, 00:00

  • MT21 Living With Orthopaedic Implants: Results of an Online Cross-Sectional Study in Hungary

    Dec 1, 2022, 00:00

  • P51 A Discrete Choice Experiment to Understand the Value of Equity

    Dec 1, 2022, 00:00

  • RWD120 Understanding Treatment Patterns, Disruptions and Potential Limitations of Tyrosine Kinase Inhibitors in ROS1+ Non-Small Cell Lung Cancer Patients in a Retrospective Review of United States Medical Transcription Records

    Dec 1, 2022, 00:00

  • HTA209 Comparative Analysis of the Transparency Committee Opinions Concerning the Added Medical Benefit Levels Depending on the Therapeutic Areas: Distribution of Innovation and Trend Assessment for 2016-2021

    Dec 1, 2022, 00:00

  • HTA37 The NICE Disease Severity Modifier: A Retrospective Analysis on Its Potential Impact on Previous Reimbursement Decisions in England

    Dec 1, 2022, 00:00

  • Differences in Evidentiary Requirements Between European Medicines Agency and European Health Technology Assessment of Oncology Drugs—Can Alignment Be Enhanced? [Editor's Choice]

    Dec 1, 2022, 00:00

  • OP15 Assessment of the Clawback and Rebate Policies on the Efficiency of Greek Public Hospitals Between 2009-2019

    Dec 1, 2022, 00:00

  • HTA75 Cost-Minimization Analysis in Iron-Deficiency Anemia Comparing Intravenous Ferric Carboxymaltose to Standard of Care in Pregnant Women in Algeria

    Dec 1, 2022, 00:00

  • EPH183 Effect of Renin-Angiotensin System Inhibitors on Alzheimer’s Disease: A Population-Based Cohort Study

    Dec 1, 2022, 00:00

  • CO34 Phase Angle, Quality of Life and Survival in Women With Head and Neck Cancer: An Uncommon Condition

    Dec 1, 2022, 00:00

  • HPR121 By Any Genes Necessary: An Eventful 12 Months in the Gene Therapy Pipeline

    Dec 1, 2022, 00:00

  • SA39 RWE Generation: Have We Reached the Tipping Point to Drive Mainstream Adoption of Automated Electronic Health Record (EHR) Extraction Technology?

    Dec 1, 2022, 00:00

  • EE350 Selective Internal Radiation Therapy Using Y-90 Resin Microspheres vs Conventional Transarterial Chemoembolization in Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: A Budget Impact Analysis in England

    Dec 1, 2022, 00:00

  • MSR10 Applying Sequence Clustering Methods to Characterize Healthcare Pathways of Patients at Different Prostate Cancer Stages in the French Nationwide Healthcare Database (SNDS)

    Dec 1, 2022, 00:00

  • EE78 Mapping the Value for Money of Precision Medicine: A Systematic Literature Review and Meta-Analysis

    Dec 1, 2022, 00:00

  • EE282 Budget Impact Analysis of a Solution for Sealant in Spain

    Dec 1, 2022, 00:00

  • HTA106 HTA and Reimbursement Timelines in the Republic of Ireland

    Dec 1, 2022, 00:00

  • PCR50 Measuring Health From a Broad Perspective: Preferences Assessed Among Various Professional Stakeholder Groups

    Dec 1, 2022, 00:00

  • EE618 Healthcare Resource Utilisation and Economic Burden Associated With Lupus Nephritis in China: A National Claims Database Study

    Dec 1, 2022, 00:00

  • HTA143 Are HTA Agencies Willing to Accept Single-Arm Trials as the Main Source of Clinical Evidence for the Assessment of Pediatric Orphan Drugs When Faced With Extenuating Ethical and Medical Circumstances?

    Dec 1, 2022, 00:00

  • CO80 Surrogate Endpoints for Overall Survival in Cutaneous Squamous Cell Carcinoma: A Meta-Regression of Clinical Trials

    Dec 1, 2022, 00:00

  • CO90 A Systematic Literature Review of Prognostic Factors and Surrogate Endpoint Analyses in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

    Dec 1, 2022, 00:00

  • EPH206 Strategies to Address Vaccine Hesitancy in Adults: A Systematic Review

    Dec 1, 2022, 00:00

  • HPR120 Negotiating New Therapeutic Indications in Italy: Which Impact on Drug Reimbursement Conditions and Timing?

    Dec 1, 2022, 00:00

  • MSR38 Can Logistic Regression (LOR) Better Predict the Significance of the Overall Survival (OS) from Surrogate Endpoints (SES) for Randomized Controlled Trials (RCTS) in Oncology? Insights From a Cross-Tumor Case Study

    Dec 1, 2022, 00:00

  • EE95 Economic Burden of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Colombia

    Dec 1, 2022, 00:00

  • PCR156 Attitude Towards Blood Donation Among the Hungarian Population

    Dec 1, 2022, 00:00

  • HTA119 Methodological Issues in Health Technology Assessment (HTA) for Re-Pricing in Japan

    Dec 1, 2022, 00:00

  • EE683 Evaluation of the Healthcare Resource Use of Haemodialysis Patients With and Without Pruritus in the UK

    Dec 1, 2022, 00:00

  • MT5 Adjusted Polygenic Risk Score Enables Personalized Cardiovascular Disease Prevention and Clinical Management

    Dec 1, 2022, 00:00

  • EE478 Do Triple Single-Pill Combinations Make a Difference in Treatment Adherence, Outcomes and Healthcare Resource Utilization in Hypertension? A Real-World Analysis of Patients on Perindopril/Amlodipine/Indapamide in Italy

    Dec 1, 2022, 00:00

  • HTA128 Reassessment of Orphan Drugs After Exceeding the 50 Mio. Euro Revenue Threshold: Effects on Added Benefit and Price Discount

    Dec 1, 2022, 00:00

  • HTA202 Learnings From First TC Opinions of Drugs Evaluated for EAP Under New Process

    Dec 1, 2022, 00:00

  • MSR73 Development and Preliminary Validation of Brief Participant-Reported Questionnaire Modules to Measure the Use of Informal Care, Social Care and Personal Expenses

    Dec 1, 2022, 00:00

  • HTA27 Implications of an EU-Wide Joint Clinical Assessment on the Scope of the Decision Problem

    Dec 1, 2022, 00:00

  • EE653 Efficacy of Targeted Drugs for the Treatment of Adults With Moderate-to-Severe Plaque Psoriasis in the Russian Federation: Number Needed to Treat and Costs Per Responder

    Dec 1, 2022, 00:00

  • RWD141 Exploration of Melanoma Patient-Generated Real-World Data Using an Ai-Based Social Listening Approach

    Dec 1, 2022, 00:00

  • PCR283 Health-Related Quality of Life in Patients With Advanced or Recurrent Endometrial Cancer Who Have Disease Progression on or Following Prior Treatment With a Platinum-Containing Therapy: Analysis of EQ-5D Utility Scores

    Dec 1, 2022, 00:00

  • SA25 Evolution of the Number of Metastatic Lung Cancer Patients before and during the COVID 19 Pandemic: A French National Hospital Database Analysis

    Dec 1, 2022, 00:00

  • EE535 The Evolution of Peer Reviewed Publications on the Subject of Economic Evaluation

    Dec 1, 2022, 00:00

  • HPR14 Identifying the Key Drivers of Biosimilar Uptake in Paris University Hospitals Using a Principal Component Analysis

    Dec 1, 2022, 00:00

  • EE423 Cost-Effectiveness of Vaccinating Adults ≥65 Years and at-Risk Individuals 18-64 Years With the 20-Valent Pneumococcal Conjugate Vaccine Versus Currently Recommended Vaccine Regimens in Sweden

    Dec 1, 2022, 00:00

  • EE483 Empagliflozin for Heart Failure Patients Irrespective of Ejection Fraction in Spain: A Cost-Effectiveness Study

    Dec 1, 2022, 00:00

  • Disparities in Access to Radiation Therapy by Race and Ethnicity in the United States With Focus on American Indian/Alaska Native People

    Dec 1, 2022, 00:00

  • EE424 Picking Petals Off the Value Flower – The Need to Consider Insurance Value for New Medical Technologies

    Dec 1, 2022, 00:00

  • EE34 Determining Cost Data for Fertility Treatment in Different European Settings

    Dec 1, 2022, 00:00

  • Medtech

    Dec 1, 2022, 00:00

  • HSD24 Evaluation of the Effectiveness of the Chest Pain Unit Department in Outcomes of Patients With Acute Coronary Syndrome

    Dec 1, 2022, 00:00

  • EE334 Cost-Effectiveness Analysis of Nivolumab as an Adjuvant Treatment of Muscle-Invasive Urothelial Carcinoma at High Risk of Recurrence in Greece

    Dec 1, 2022, 00:00

  • Advances in Cost-Effectiveness Analysis Methods

    Dec 1, 2022, 00:00

  • CO170 Efficacy and Safety of Golimumab in Pediatric Ulcerative Colitis: A Systematic Literature Review

    Dec 1, 2022, 00:00

  • PCR256 Humanistic Burden and Prevalence of Mental Conditions Among COVID-19 Patients in Japan and China

    Dec 1, 2022, 00:00

  • MT9 Cost-Utility of Bone Conduction Implants for Conductive or Mixed Hearing Loss or Single-Sided Deafness: A Decision Analysis

    Dec 1, 2022, 00:00

  • CO27 Evaluation of Antiseptics and the Microbiological Environment Regarding Complications of Phlebitis Caused by Peripheral Cannulas

    Dec 1, 2022, 00:00

  • EE406 Colorectal Cancer Screening - Benefit-Harm and Cost-Effectiveness Analysis of Population-Wide Screening Strategies in Austria

    Dec 1, 2022, 00:00

  • CO164 Real-World Outcomes and Treatments Patterns of Metastatic Castration-Resistant Prostate Cancer Patients: An Italian Retrospective Study

    Dec 1, 2022, 00:00

  • PCR105 Examination of Surgical Indications and Previous Hip Replacement Surgery Among Hip Prosthesis Patients in State and Private Health Care

    Dec 1, 2022, 00:00

  • EPH22 A Systematic Literature Review of the Epidemiology Associated With Human Monkeypox in Children and Adults in India

    Dec 1, 2022, 00:00

  • RWD116 Consequences of the Poor Anticoagulation Control of Patients With Non-Valvular Atrial Fibrillation Treated With Vitamin K Antagonists

    Dec 1, 2022, 00:00

  • EE229 Cost-Effectiveness Analysis of Eremumab (Aimovig®) for the Preventive Treatment of Migraine in Spain

    Dec 1, 2022, 00:00

  • CO87 Reductions in Exacerbations and Improvements in Lung Function and Asthma Control in Children With Moderate-to-Severe Type 2 Asthma Analyzed by High- or Medium-Dose of Inhaled Corticosteroids at Baseline

    Dec 1, 2022, 00:00

  • PCR232 The Use of EuroQol EQ-5D in the Middle East and North Africa Region: A Systematic Review

    Dec 1, 2022, 00:00

  • EE593 The Budget Impact of Introducing a Rapid Test for the Screening of Carbapenemase-Producing Organisms Among Hospitalized Patients in China

    Dec 1, 2022, 00:00

  • HTA237 Cost-Effectiveness Analysis of Ofatumumab for Relapsing Remitting Multiple Sclerosis Treatment in Italy

    Dec 1, 2022, 00:00

  • EPH177 Assessing Student Pharmacists’ Knowledge and Perceptions of Electronic Nicotine Delivery Systems (ENDS) – A Cross Sectional Study at One College of Pharmacy

    Dec 1, 2022, 00:00

  • HPR90 A Quasi-Experimental Study of the Effects of the Affordable Care Act (ACA) Marketplaces Subsidies on Access to Care and Healthcare Utilization of Nonelderly Adults With Chronic Conditions

    Dec 1, 2022, 00:00

  • PCR96 Effects of Intravenous Iron Infusion Frequency, Duration, and Safety on Quality of Life: Results of a Time Trade-Off Study in Patients With Iron Deficiency Anemia in China

    Dec 1, 2022, 00:00

  • PCR100 Reading and Labeling Medical Discharge Summaries Using Artificial Intelligence to Improve Medical Discharge Process

    Dec 1, 2022, 00:00

  • MSR51 Predictors of Hospitalization in Patients With Newly Diagnosed Major Depressive Disorder: A Real-World Evidence Study

    Dec 1, 2022, 00:00

  • EE174 Public Health Impact of Switching From a Trivalent to a Quadrivalent Inactivated Influenza Vaccine in Ecuador

    Dec 1, 2022, 00:00

  • MSR118 Machine Learning Approaches Towards Identification of Phenotypes in Various Diseases Using Electronic Health Records

    Dec 1, 2022, 00:00

  • MSR11 Evaluating the Impact of Exact Logistic Regression on Matching Adjusted Indirect Comparisons (MAICs) of Treatments Between Trials: A Simulation Study

    Dec 1, 2022, 00:00

  • EE407 Budget Impact Analysis of the Use of Emicizumab in Prophylaxis for Severe Hemophilia A and Inhibitors in the Pediatric Population of the Dominican Republic

    Dec 1, 2022, 00:00

  • EE265 Health, Productivity and Budget Impact of Vaccinating 50-64 Year Old Employees in Austria Against Herpes Zoster With Recombinant Zoster Vaccine

    Dec 1, 2022, 00:00

  • EE277 Cost-Effectiveness of Lanreotide ATG Verse Octreotide for the Treatment of Acromegaly in China

    Dec 1, 2022, 00:00

  • EE321 Use of Single-Arm Trials in NICE Reviews of Oncology Drugs

    Dec 1, 2022, 00:00

  • RWD81 Analysis of Clinical Outcomes, Health Resource Use and Costs of Patients With Non-Valvular Atrial Fibrillation Treated With Apixaban vs Acenocoumarol in Routine Clinical Practice in Spain

    Dec 1, 2022, 00:00

  • PCR54 Patient Preferences With Rheumatological or Dermatological Diseases Regarding Electronic Injection Devices for the Administration of Etanercept in Colombia

    Dec 1, 2022, 00:00

  • HPR115 When to Expect Economic Appraisal in France? A Study Based on 2021 Appraisal

    Dec 1, 2022, 00:00

  • SA73 Addressing Unmet Needs of Patients With Neuronopathic Gaucher Disease Type 2 and Type 3: Creation of the GARDIAN Patient Registry

    Dec 1, 2022, 00:00

  • CO12 Prevalence and Factors Associated With Hypoparathyroidism After Total Thyroidectomy for Thyroid Cancer: A French Nationwide Claims Database Study

    Dec 1, 2022, 00:00

  • Public Health

    Dec 1, 2022, 00:00

  • HPR70 Developing the Risk-Adjusted Capitation Payment for Patients With Diabetes Mellitus in China: Results From Administrative Data in Tianjin

    Dec 1, 2022, 00:00

  • P43 Navigating the Maze of Standard and Novel Population-Adjusted Indirect Comparison (PAIC) Methods

    Dec 1, 2022, 00:00

  • EE99 Cost-Effectiveness of Percutaneous Closure of a Patent Foramen Ovale (PFO) Versus Antiplatelet Therapy After Stroke: A Trial and Model Based Economic Evaluation of the French Close Randomised Controlled Trial

    Dec 1, 2022, 00:00

  • MSR19 An Update on Real-Time Application of Machine Learning Programs to Improve Cardiovascular Risk Prediction in European Population

    Dec 1, 2022, 00:00

  • PCR155 A Theoretical Model on Pediatric Nurses’ Burnout, Wellbeing, and Patient Safety

    Dec 1, 2022, 00:00

  • Real-World Evidence to Inform Healthcare Decision Making

    Dec 1, 2022, 00:00

  • HTA260 Informal Carer Disutility: How Many Caregivers Are Captured in Cost-Utility Analyses of Treatments for Rare Diseases Submitted for NICE Highly Specialised Technology Appraisals?

    Dec 1, 2022, 00:00

  • EE405 A UK Cost-Minimisation Analysis of Brolucizumab Versus Aflibercept in Diabetic Macular Oedema (DMO)

    Dec 1, 2022, 00:00

  • EE137 Evaluating the Effects of the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model Risk Factor Progression Equations on Cost-Utility Outcomes in Type 2 Diabetes: Analyses Using the Prime Diabetes Model

    Dec 1, 2022, 00:00

  • PCR134 Uncertainties in Evaluating Patient and Caregiver Health-Related Quality of Life and Disease Burden in NICE HST Submissions

    Dec 1, 2022, 00:00

  • HTA78 Evaluations of Cost-Utility Analyses of Pharmaceuticals Receiving Market Authorization Based on Single-Arm Trials in the Netherlands

    Dec 1, 2022, 00:00

  • EE507 Insulin Degludec/Insulin Aspart Versus Basal+Bolus Insulin Treatment (Insulin Glargine U100 Insulin Aspart) in T2D in India: A Short-Term Cost-Effectiveness Analysis Based on the Step-By-Step Clinical Trial

    Dec 1, 2022, 00:00

  • PCR59 A Systematic Literature Review of Humanistic Burden in Huntington's Disease

    Dec 1, 2022, 00:00

  • EE221 Healthcare Resource Utilization and Costs of Myotubular Myopathy in England

    Dec 1, 2022, 00:00

  • MSR105 Artificial Intelligence/Machine Learning (AI/ML) Techniques for Risk/Outcomes Prediction in Patients With Myocardial Infarction (MI) – A Targeted Literature Review (TLR)

    Dec 1, 2022, 00:00

  • RWD51 Demonstrating Internal and External Validity in Real-World Datasets: A Case Study in MET Exon 14 (METex14) Skipping Non-Small Cell Lung Cancer (NSCLC)

    Dec 1, 2022, 00:00

  • CO55 Radiographic Progression-Free Survival (RPFS) as a Surrogate Endpoint for Overall Survival (OS) in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer (MCRPC): A Correlation Meta-Analysis

    Dec 1, 2022, 00:00

  • EPH143 Hepatic Disorders of Pirfenidone or Nintedanib in Patients with Idiopathic Pulmonary Fibrosis (IPF): A Systematic Review

    Dec 1, 2022, 00:00

  • EPH119 The Economic Burden of Illness (BOI) of the Globally Spreading Chikungunya Virus (CHIKV): A Systematic and Targeted Literature Review (SLR AND TLR)

    Dec 1, 2022, 00:00

  • HSD31 Analysis of the Balanced Scorecard's Managerial Subdimensions in Health Care Organizations During the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • PCR211 VOCAL (Views of Ovarian Cancer Patients and Their Caregivers-How Maintenance Therapy Affects Their Lives) Study: Cancer-Related Burden and Quality of Life of Caregivers

    Dec 1, 2022, 00:00

  • Innovative Methods in Indirect Treatment Comparisons

    Dec 1, 2022, 00:00

  • RWD159 Use of RWD to Support Healthcare Decision Making in Japan: The Devil Lies in the 'D' - How Is the Data Landscape Evolving in Japan?

    Dec 1, 2022, 00:00

  • EPH101 Application Processes for International Classification of Disease (ICD)-11 Update and Revision Proposals

    Dec 1, 2022, 00:00

  • HSD99 Analysis of the Balanced Scorecard's Customer Subdimensions in Health Care Organizations During the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • PCR118 Valuation of the EQ Health and Well-being Short Using Time Trade-Off and Discrete Choice Experiments: A Feasibility Study

    Dec 1, 2022, 00:00

  • EPH64 Public Health Impact of COVID-19 in French Ambulatory Patients With at Least One Risk Factor for Severe Disease

    Dec 1, 2022, 00:00

  • EPH104 Valuing the Impact of Incorporating an Acellular Hexavalent Vaccine in the National Vaccination Scheme of Peru in the Context of COVID-19

    Dec 1, 2022, 00:00

  • PCR61 The Burden of Spinal Muscular Atrophy Type 2 (SMA2) on Caregivers in Japan, United Kingdom, and United States: Results of a Global Survey

    Dec 1, 2022, 00:00

  • HTA235 Time to Health Technology Assessment of New Medicinal Products in Greece

    Dec 1, 2022, 00:00

  • P59 Automated Literature Screening Using Artificial Intelligen A Meta-Analysis of Different Algorithm Results

    Dec 1, 2022, 00:00

  • EE589 Cost-Effectiveness of Once-Daily Somatropin From Sandoz Versus Once-Weekly Somatrogon for the Treatment of Growth Hormone Deficiency in Children and Adolescents

    Dec 1, 2022, 00:00

  • EE139 Cost-Effectiveness of Poly ADP-Ribose Polymerase (PARP) Inhibitors in Cancer Treatment: A Systematic Review

    Dec 1, 2022, 00:00

  • CO105 Long-Term Benefit of Ataluren Treatment in Non-Sense Duchenne Muscular Dystrophy Versus Standard of Care

    Dec 1, 2022, 00:00

  • HTA123 An Exploration of Patient Involvement in NICE and SMC Appraisals of Breast and Ovarian Cancer Therapies

    Dec 1, 2022, 00:00

  • EE346 Comparison of Diagnosis, Administration, and Treatment-Related Cost of Targeted Radiopharmaceutical Therapies in Patients With Metastatic Castration-Resistant Prostate Cancer (MCRPC) From a Third-Party Payer Perspective

    Dec 1, 2022, 00:00

  • RWD103 Real-World Results of Reimbursed Immune Checkpoint Inhibitors in Taiwan’s Health Insurance System

    Dec 1, 2022, 00:00

  • HPR108 Impact of COVID-19 Pandemic on the Decision Process of the Italian Medicine Agency: A Quantitative Assessment

    Dec 1, 2022, 00:00

  • CO72 Predicting Sojourn Times by Dementia Stages: Evidence From 76,747 Patients in the Swedish National Registry for Cognitive Disorders (SVEDEM)

    Dec 1, 2022, 00:00

  • CO110 Systematic Literature Review (SLR) and Meta-Analysis (MA) of Clinical Outcomes for Second-Line and Higher (≥2L) Targeted Therapies for Advanced Colorectal Cancer (aCRC)

    Dec 1, 2022, 00:00

  • EPH205 Characterizing the Burden of Disease in Patients With Asthma or COPD With Raised Versus Low Eosinophils: A UK Biobank Study

    Dec 1, 2022, 00:00

  • EE57 Recombinant Zoster Vaccine for High-Risk Ageing Adults in the Netherlands: Cost-Effectiveness and Value of Information Analyses

    Dec 1, 2022, 00:00

  • EE76 Budget Impact of Subcutaneous Infliximab in Comparison to Intravenous Infliximab in the Management of Autoimmune Diseases in Greece

    Dec 1, 2022, 00:00

  • HSD17 Treatment Pattern of the Opioid Injection Prescriptions in South Korea

    Dec 1, 2022, 00:00

  • HSD76 Analysis of the Balanced Scorecard's External Subdimensions in Health Care Organizations During the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • EE389 Medical Cost Reduction in Rural Residents Through a Health Promotion Program in Japan

    Dec 1, 2022, 00:00

  • EPH210 Impact of Distance Learning on Development of Emotional Intelligence of Medical Bachelor Students

    Dec 1, 2022, 00:00

  • EE5 Cost-Utility Analysis of Aripiprazole, Olanzapine Branded Generic, and Olanzapine Generic on Stable Phase of Schizophrenia Patient at Mental Health Hospital in Jakarta

    Dec 1, 2022, 00:00

  • SA50 Claims-Based Estimates of Bleeding Rates in Hemophilia B Patients on Factor IX Therapy in the United States

    Dec 1, 2022, 00:00

  • HSD47 Evidence Synthesis on Inappropriate Use of Clinical Practices in Spain: A Scoping Review

    Dec 1, 2022, 00:00

  • PCR152 Underutilization of a Validated Treatment Satisfaction Instrument in Inflammatory Bowel Disease

    Dec 1, 2022, 00:00

  • MSR55 Extraction of Ejection Fraction From Clinical Notes Using a Pretrained Albert-for-Question-Answering Model

    Dec 1, 2022, 00:00

  • PCR42 Examination of Quality of Life and Sexual Functions Among Women With Cervical Cancer

    Dec 1, 2022, 00:00

  • Reviewer Acknowledgment

    Dec 1, 2022, 00:00

  • EE283 Health Economic Impact of Medication Non-Adherence to Direct Oral Anticoagulants in Austria

    Dec 1, 2022, 00:00

  • RWD59 Disparity in Breast Cancer Female Undergoing Reconstructive Procedures: A Real-World Analysis

    Dec 1, 2022, 00:00

  • MSR126 Economic and Humanistic Burden in Patients With Obstructive Hypertrophic Cardiomyopathy - A Systematic Literature Review

    Dec 1, 2022, 00:00

  • EE129 Cost-Effectiveness of Ofatumumab Versus Ocrelizumab in Patients With Active Relapsing Multiple Sclerosis in Portugal

    Dec 1, 2022, 00:00

  • PCR75 Comparing Choice Share Prediction Methods for Discrete Choice Experiments: A Case Study With Hypomethylating Agents in Myelodysplastic Syndromes

    Dec 1, 2022, 00:00

  • SA82 A Bayesian Network Meta-Analysis of the Tyrosine Kinase Inhibitors (TKI) for ALK-Positive Advanced Non-Small Cell Lung Cancer With or Without Brain Metastasis

    Dec 1, 2022, 00:00

  • MT6 Real World Clinical Data on the Use of a Natural Molecular Complex for the Treatment of Irritable Bowel Syndrome in Specialist Daily Practice

    Dec 1, 2022, 00:00

  • OP2 Organizational Impact Model Associated With Switching From Intravenous (IV) to Subcutaneous (SC)

    Dec 1, 2022, 00:00

  • RWD75 Healthcare Cost for Patients With Chronic Rhinosinusitis With Nasal Polyps and Comorbid Asthma

    Dec 1, 2022, 00:00

  • EE438 Assessing the Cost-Effectiveness of Axicabtagene Ciloleucel Compared With Other CAR T-Cell Therapies in the Treatment of Diffuse Large B-Cell Lymphoma in the UK

    Dec 1, 2022, 00:00

  • HTA259 Overlaps and Differences in the PICO Criteria Between the Different EU Countries

    Dec 1, 2022, 00:00

  • EE602 Budget Impact Analysis of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate for COPD in the Italian Healthcare System

    Dec 1, 2022, 00:00

  • RWD105 Clinical Differences and Patient Reported Outcomes Between Insufficient Responders and Responders to Prescribed Acute Migraine Treatment: Results From a Real-World Patient Survey in China

    Dec 1, 2022, 00:00

  • HSD45 Breast Cancer Biopsy Rates in Chile: Is There Justification for Adopting Innovative Anatomic Pathology Technologies in Public Providers?

    Dec 1, 2022, 00:00

  • EPH201 Systematic Review of the Accuracy of T-Cell Receptor Excision Circle (TREC)-Based Newborn Screening for Severe Combined Immunodeficiency (SCID)

    Dec 1, 2022, 00:00

  • CO148 Time in Remission as an Alternative Outcome Measure for Ankylosing Spondylitis: A 4-Year Prospective Study of 1900 Users of Anti-TNF

    Dec 1, 2022, 00:00

  • EE91 Economic Evaluation of Durvalumab for the Treatment of Patients With Stage III Unresectable Locally Advanced Non-Small Cell Lung Cancer Whose Disease Has Not Progressed After Platinum-Based Chemoradiation Therapy

    Dec 1, 2022, 00:00

  • MSR58 How Do Mapping Studies Take into Account the Methodological Challenges of Repeated Measurements From the Same Individuals Over Time?

    Dec 1, 2022, 00:00

  • HTA222 How to Increase the Public Legitimacy of Healthcare Resource Allocation Processes: Lessons From an Israeli Case Study

    Dec 1, 2022, 00:00

  • CO20 Predicted Time to Wheelchair and Ventilation Events Comparing Avalglucosidase Alfa (AVA) Versus (vs) Alglucosidase Alfa (ALG) Using a Model of Late-Onset Pompe Disease (LOPD)

    Dec 1, 2022, 00:00

  • CO93 Rates of Disease-Related Hospitalization and Colectomy in Real-World Patients With Ulcerative Colitis on Anti-Tnf Agents: Evidence From a Systematic Review

    Dec 1, 2022, 00:00

  • CO175 Systematic Literature Review of Outcomes in Patients With Advanced Basal Cell Carcinoma (ABCC) Who Progressed on or Are Intolerant to Hedgehog Inhibitors (HHI)

    Dec 1, 2022, 00:00

  • EE337 An Economic Assessment of Incorporating an Acellular Hexavalent Vaccine as Part of the National Immunization Program of Peru

    Dec 1, 2022, 00:00

  • EE64 Healthcare Resource Utilisation and Medical Costs Among Patients With High-Grade Serous Ovarian Cancer in a Real-Life Setting in Finland: The OCRWE-Finland Study

    Dec 1, 2022, 00:00

  • EPH160 Burden of Illness (BOI) and Paucity of Treatment of the Mosquito-Borne Chikungunya Virus (CHIKV)

    Dec 1, 2022, 00:00

  • EE580 Costs of Chronic Kidney Failure and Diabetic Nephropathy in Turkiye

    Dec 1, 2022, 00:00

  • PCR290 Patient Preferences and Cost-Benefit of Hypertension and Hyperlipidemia Collaborative Management Model Between Pharmacies and Primary Care in Portugal: A Discrete Choice Experiment Alongside a Trial (USFARMÁCIA®)

    Dec 1, 2022, 00:00

  • P38 One Size Does Not Fit All: Calculating the Cost-Effectiveness of Multiple Indications of Pembrolizumab in the Netherlands

    Dec 1, 2022, 00:00

  • RWD114 Investigating the Impacts of Comorbid Conditions on Costs and Length of Stay in Secondary Care Among Adults Infected With Influenza in England

    Dec 1, 2022, 00:00

  • HTA124 Real-World Data to Inform Health Technology Assessments in England: A Review of Submissions to the National Institute for Health and Care Excellence Since 2018

    Dec 1, 2022, 00:00

  • SA32 Adapting PROs Evaluation to COVID Context – The Case of ASCEND Study

    Dec 1, 2022, 00:00

  • RWD153 Attributable Costs of Breast Cancer in Colombia: A Cost-of-Illness Study Based on Administrative Claims Databases

    Dec 1, 2022, 00:00

  • HTA87 Evaluating the Framework and Evolution of the Italian Ministry of Health HTA Reports

    Dec 1, 2022, 00:00

  • SA15 Propensity Score Matching: Role of Clinical Expertise in a Data-Driven Approach to Model Selection

    Dec 1, 2022, 00:00

  • CO89 Integrated Analysis of Efficacy and ICU Length of Stay Data From Phase 2 and Phase 3 Trials of Rezafungin for the Treatment of Invasive Candidiasis and/or Candidemia

    Dec 1, 2022, 00:00

  • SA6 Challenges in Economic Modelling of Adjuvant Cancer Therapy for Health Technology Assessments

    Dec 1, 2022, 00:00

  • CO163 The Increasing Use of Population-Adjusted Indirect Comparisons in the NICE Health Technology Assessment (HTA) Submission Process and the Response to These Methods

    Dec 1, 2022, 00:00

  • HTA61 Challenges in Selecting Relevant Comparator Therapies in Indications With Low Evidence Using the Example of German Benefit Assessments With the Appropriate Comparator Therapy “Treatment of Physicians Choice"

    Dec 1, 2022, 00:00

  • HSD53 Analysis of the Balanced Scorecard's Internal Subdimensions in Health Care Organizations During the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • EE381 Cost-Effectiveness Analysis of Atrial Fibrillation Screening in the Elderly Population of Taiwan

    Dec 1, 2022, 00:00

  • HSD25 Occupational Burnout Among Pediatric Neurologists Is Associated with Therapeutic Inertia in the Management of Spinal Muscular Atrophy

    Dec 1, 2022, 00:00

  • PCR84 Myasthenia Gravis Patients Have Lower Eq-5D-5L and HUI3 Utility Values Than a Matched Sample of the General Population: Analysis of Digitally Collected Observational Data from 8 Countries

    Dec 1, 2022, 00:00

  • RWD104 Delayed Diagnosis Amongst gMG Patients: Results From a European Real-World Study

    Dec 1, 2022, 00:00

  • EE190 Association of Total Annual Costs of Duchenne Muscular Dystrophy With Disease Severity

    Dec 1, 2022, 00:00

  • EPH123 Estimating ADHD Prevalence and ADHD-Associated Health Care Costs Based on Claims Data

    Dec 1, 2022, 00:00

  • HTA187 Best Practices for the Development of Budget Impact Models at Regional Level

    Dec 1, 2022, 00:00

  • HPR25 Patient Organisations' Submissions to the Pharmaceutical Pricing Board in Finland

    Dec 1, 2022, 00:00

  • RWD80 The Disease Burden of Invasive Candidiasis in Germany: A Non-Interventional, Retrospective Cohort Analysis of Real-World Data

    Dec 1, 2022, 00:00

  • EE436 General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations

    Dec 1, 2022, 00:00

  • EE640 Quantifying Out-of-Pocket Expenses in Patients With Prurigo Nodularis

    Dec 1, 2022, 00:00

  • RWD64 Identifying Patient-Level Social Determinants of Health in Unstructured Clinical Notes From Electronic Health Records

    Dec 1, 2022, 00:00

  • EE513 Health Economic Evaluation Incorporating Mixture Cure Survival Analysis of Nivolumab Plus Ipilimumab for Previously Untreated Metastatic NSCLC

    Dec 1, 2022, 00:00

  • HTA10 Carer Health-Related Quality of Life in National Institute for Health and Care Excellence (NICE) Appraisals: An Update of the Pennington Review

    Dec 1, 2022, 00:00

  • EPH103 Vitiligo in Italy Through Administrative Healthcare Data

    Dec 1, 2022, 00:00

  • RWD145 The Direct Cost Savings and Indirect Value of Using Artificial Intelligence With Clinical Disease Specific Quality Register Data - Case Helsinki University Eye Clinic: Cataract Register and Retina Register

    Dec 1, 2022, 00:00

  • PCR260 Cross-Sectional Quantitative Evaluation of a Novel Patient-Reported Outcome Measure in Familial Chylomicronemia Syndrome

    Dec 1, 2022, 00:00

  • PCR279 Value-Based Assessment of Clinical Trial Outcomes: A Hypothetical Example Using the Childhood Autism Rating Scale in Autism Spectrum Disorder

    Dec 1, 2022, 00:00

  • MSR92 Challenges to Implementing Real-World Evidence (RWE)

    Dec 1, 2022, 00:00

  • CO134 Systematic Review of the Impact of Early Versus Late Diagnosis and/or Hematopoietic Stem Cell Transplantation (HSCT) for Severe Combined Immunodeficiency (SCID)

    Dec 1, 2022, 00:00

  • EE227 Healthcare Resource Utilization and Costs Among Patients with Moderately-to-Severely Active Crohn’s Disease Treated with Ustekinumab: Real-World Evidence

    Dec 1, 2022, 00:00

  • RWD150 Characteristics of Plaque Psoriasis Patients Initiating Guselkumab by Country: A Multi-National, Real-World Survey of Dermatology Practices

    Dec 1, 2022, 00:00

  • PCR23 Humanistic Burden and Mental Conditions Among Cancer Patients Before and During the COVID-19 Pandemic in Japan and China

    Dec 1, 2022, 00:00

  • HSD50 Evaluating the Pediatric Prescribing Pattern in a Health Facility in Nigeria

    Dec 1, 2022, 00:00

  • RWD73 Epidemiology and Burden of Sickle Cell Disease in Fran Real-Life Analysis Using Data From the Echantillon Generaliste Des Bénéficiaires (EGB)

    Dec 1, 2022, 00:00

  • HTA266 Hierarchical Network Meta-Analysis Models for the Inclusion of Randomised and Observational Comparative Studies in Evidence Synthesis

    Dec 1, 2022, 00:00

  • HPR209 The Unmet Medical Needs Concept – A Structured Analysis of Its Application in Authorisation and Belgian Reimbursement Practices

    Dec 1, 2022, 00:00

  • EE138 Healthcare Resource Use (HCRU) and Associated Costs Among Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CAR-T Cells in France – A Real-World Study Using Data From PMSI

    Dec 1, 2022, 00:00

  • EPH84 Prevalence of Polysubstance Use of Opioids in Pregnant Women and Medication-Assisted Treatment: Evidence from the United States Treatment Episode Data Set

    Dec 1, 2022, 00:00

  • PCR263 What Does the EQ-5D-Y-5L Measure in Comparison to Other Generic Paediatric Health Related Quality of Life Instruments?

    Dec 1, 2022, 00:00

  • HTA126 Procedural Issues in Health Technology Assessment (HTA) for Re-Pricing in Japan

    Dec 1, 2022, 00:00

  • EPH166 Idiopathic Pulmonary Fibrosis (IPF : Epidemiology and Characteristics of Patients in Morocco

    Dec 1, 2022, 00:00

  • HSD14 Lacking Observance of the Guidelines on Dyslipidaemias as Possible Reason for Low LDL-C Goal Attainment in Patients at High and Very High Cardiovascular Risk

    Dec 1, 2022, 00:00

  • EE378 Cost-Effectiveness Analysis of a Digital Health Application (DIGA) Plus Best Supportive Care (BSC) Compared to BSC in German Episodic Migraine Patients

    Dec 1, 2022, 00:00

  • MSR142 Combination State Sequence and Process Mining Approach to Develop a Patient-Level Model of Heterogenous Clinical Pathways in Osteoporosis

    Dec 1, 2022, 00:00

  • EE236 Hospital Incidence and Medical Costs of Polycythemia Vera in Spain: A Retrospective Database Analysis

    Dec 1, 2022, 00:00

  • EE218 Cost-Utility Analysis Comparing Robot-Assisted Radical Prostatectomy Versus Robotic Stereotactic Body Radiotherapy With Artificial Intelligence for the Treatment of Prostate Cancer

    Dec 1, 2022, 00:00

  • HTA67 Do Manufacturers Still See Value in Submitting Evidence for a NICE Appraisal in England? Comparing and Contrasting Terminated Appraisals Between Oncology and Non-Oncology and Monotherapies and Combination Products

    Dec 1, 2022, 00:00

  • EE571 Cost-Effectiveness of Maribavir for Post-Transplant Refractory Cytomegalovirus Infection With or Without Resistan A UK Perspective

    Dec 1, 2022, 00:00

  • CO17 Real-World Data (RWD) Collection Alongside Early Access to Medicines Scheme (EAMS) - Nivolumab in Advance Squamous Cell Oesophageal Cancer After Prior Chemotherapy

    Dec 1, 2022, 00:00

  • MSR99 Cartography of Biostatistics and Machine Learning Methods to Identify Prognostic Factors

    Dec 1, 2022, 00:00

  • SA20 Clinical, Humanistic, and Economic Burden in Fibrodysplasia Ossificans Progressiva (FOP): A Systematic Literature Review

    Dec 1, 2022, 00:00

  • SA76 Burden of Illness in Patients with Alzheimer’s Disease: A Systematic Review of Incidence, Prevalence, Comorbidities, Disability and Mortality

    Dec 1, 2022, 00:00

  • PCR28 Utility Values Derived From Canadian Adults With Toenail Onychomycosis With and Without Comorbid Diabetes Mellitus: A Study Using the Health Utilities Index®

    Dec 1, 2022, 00:00

  • CO37 Reduction of Length of Hospital Stay in Patients Undergoing Major Planned Orthopedic Surgery After the Implementation of the Patient Blood Management (PBM) in Italy

    Dec 1, 2022, 00:00

  • EE13 Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Portugal

    Dec 1, 2022, 00:00

  • HTA205 Time to Reimbursement Decisions for Personalized Medicines in the UK and France

    Dec 1, 2022, 00:00

  • RWD25 The Phollow Cohort: Real-World Therapeutic Adherence to Blood Glucose Lowering Drugs (Excluding Insulins) in Portugal

    Dec 1, 2022, 00:00

  • EPH163 Burden of Diffuse Large B-Cell Lymphoma (DLBCL) in Germany – A Retrospective Statutory Health Insurance Claims Data Analysis

    Dec 1, 2022, 00:00

  • PCR37 Understanding Symptoms and Meaningful Change in Patient Global Impression Scales for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer (adv/met NSCLC): A Qualitative Research Study

    Dec 1, 2022, 00:00

  • CO71 EU Joint Clinical Assessment Initiative: Process and Access Strategy Implications

    Dec 1, 2022, 00:00

  • CO57 Modeling Adherence to Positive Airway Pressure Therapy in Women With Obstructive Sleep Apnea

    Dec 1, 2022, 00:00

  • EPH158 Examination of the Glenohumeral Joint and Rotator Cuff Condition Among Youth Kayak-Canoe Athletes

    Dec 1, 2022, 00:00

  • EE373 Assessment of Extent and Quality of Pharmacoeconomic Studies in India Using Quality of Health Economic Studies (QHES) Score: A Targeted Literature Review

    Dec 1, 2022, 00:00

  • CO103 Prognostic Models for Short-Term Annual Risk of Severe Acute Complications and Mortality in Patients Living With Type 2 Diabetes Using a National Medical Claim Database

    Dec 1, 2022, 00:00

  • HPR80 Assessing Performance of TB Management Through NTEP By 2025: An Initiative From the Indian Government a Roadmap Ahead of Sustainable Goal in India 2030

    Dec 1, 2022, 00:00

  • EE428 Cost-Effectiveness of Collagen Laminin-Based Dermal Matrix Combined With Resveratrol Microparticles in Treatment of Diabetic Foot Ulcer Treatment in Turkey

    Dec 1, 2022, 00:00

  • HSD15 Biosimilars and Originators: Utilization and Costs in Lombardy Region

    Dec 1, 2022, 00:00

  • HPR93 Turkiye-Based Health Economics and Outcome Studies Published in ISPOR

    Dec 1, 2022, 00:00

  • EE66 Tiered Pricing and Other Alternative Mechanisms for Equitative Access to Vaccines in Latin America: A Narrative Review of the Literature

    Dec 1, 2022, 00:00

  • EPH66 Underground Economy - A Parameter of Social Influence During the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • EE523 Assessing the Economic and Quality of Life Impact of Treatment in Duchenne Muscular Dystrophy

    Dec 1, 2022, 00:00

  • EPH175 Identification and Quantification of Atopic Dermatitis Patients With Insufficient Disease Control Under Conventional Systemic Treatments in Germany: A Feasibility Study

    Dec 1, 2022, 00:00

  • EE143 Cost-Effectiveness of Ofatumumab Compared with Other Disease-Modifying Therapies for the Treatment of Relapsing Multiple Sclerosis in Greece

    Dec 1, 2022, 00:00

  • EE308 Budget Impact Analysis (BIA) of Medical Activity on Fractional Flow Reserve Measurement (FFR) for Functional Assessment of Epicardial Stenoses in Patients With Stable Coronary Heart Disease

    Dec 1, 2022, 00:00

  • RWD10 Measuring Patient Satisfaction From Patient Reported Outcomes (PRO) Application Embedded in the Hospital's Treatment Pathway in Finland

    Dec 1, 2022, 00:00

  • CO30 Therapeutic Role of Melatonin in Pediatric Migraine: A Systematic Review and Meta-Analysis

    Dec 1, 2022, 00:00

  • MSR127 Generalizability of Trial-Based Economic Evaluations. Methods to Account for Covariates and Impact on Cost-Effectiveness and Value of Information

    Dec 1, 2022, 00:00

  • HSD1 Treatment With Dual and Triple Therapy in Chronic Obstructive Pulmonary Disease in Line With Current Guidelines Reduces the Carbon Footprint

    Dec 1, 2022, 00:00

  • EPH174 Utilization of Intravenous Iron Preparations for Iron Deficiency Anemia: A Longitudinal Study Using a Japanese Health Insurance Claims Database With Annual Health Check-Ups in 2018-2021

    Dec 1, 2022, 00:00

  • CO4 How Can the Long-Term Benefits and Harms of Screening Be Transparently Quantified and Contrasted for Informed Decision-Making? Colorectal Cancer Screening for Persons at Familial Risk (FARKOR)

    Dec 1, 2022, 00:00

  • CO97 Assessment of Enhanced Efficacy of Multiple CYTOPOINT Injections

    Dec 1, 2022, 00:00

  • HTA60 Icosapent Ethyl in Addition to Statins Is a Cost-Effective Treatment in Patients at High Cardiovascular Risk With Elevated Triglycerides and Established Cardiovascular Disease or Diabetes With Risk Factor in the Netherlands

    Dec 1, 2022, 00:00

  • RWD46 Validation of Race in Cerner Real-World Data: Understanding Missing and Uninterpretable Data

    Dec 1, 2022, 00:00

  • PCR31 Patient and Caregiver Preferences for the Treatment of Duchenne Muscular Dystrophy: A Quantitative Patient Preference Study

    Dec 1, 2022, 00:00

  • MSR76 Evaluation of the Use of Topic Modelling (TM) to Support Systematic Literature Review (SLR) Updates for Screening Truncation of Non-Relevant Citations

    Dec 1, 2022, 00:00

  • RWD137 Changing Priorities Among Physician Reported Reasons for Choice of Pharmacological gMG Treatments Across 5 European Countries

    Dec 1, 2022, 00:00

  • EPH148 Knowledge of Abortion and Perception Towards Legalization of Abortion Among Students in a Nigerian University

    Dec 1, 2022, 00:00

  • EE674 Economic Burden of Patients With Glioblastoma in Five Key European Countries: A Systematic Review

    Dec 1, 2022, 00:00

  • EE23 Costs, Consequences and Budget Impact of Implementing a 2-Dose or 3-Dose Rotavirus Vaccine in the United Kingdom

    Dec 1, 2022, 00:00

  • MT38 Economic Value of Antibiotic-Impregnated External Ventricular Drain Catheters in Cerebrospinal Fluid Diversion Procedures

    Dec 1, 2022, 00:00

  • HPR40 Cost-Effectiveness and Budget Impact of Baloxavir Marboxil in the Netherlands Based on Post-COVID Influenza Season Scenarios

    Dec 1, 2022, 00:00

  • EE630 A Cost-Effectiveness Analysis (CEA) of Adjuvant Nivolumab for Patients With Resected Esophageal Cancer (EC) or Gastroesophageal Junction Cancer (GEJC) in France

    Dec 1, 2022, 00:00

  • EPH88 Determinants of Caregiving Burden Among Caregivers of Adult Patients With Beta-Thalassemia Major in China

    Dec 1, 2022, 00:00

  • The Role of Real-World Data in HTA and Regulatory Decision-Making

    Dec 1, 2022, 00:00

  • CO151 Estimating the Benefit of Esketamine Nasal Spray Versus Real-World Treatment on Patient-Reported Functional Remission: Results From the Iceberg Study

    Dec 1, 2022, 00:00

  • EE102 Economic and Organisational Impact of an Innovative Treatment With Extended Durability for Retinal Diseases Reducing the Annual Frequency of Intravitreal Injections in France

    Dec 1, 2022, 00:00

  • MSR60 Literature Review of Statistical Methods Comparisons Through Simulations When Using External Control Arm for Regulatory or HTA Submissions

    Dec 1, 2022, 00:00

  • HPR173 Criteria to Define Rare Diseases and Orphan Drugs: Systematic Literature Review

    Dec 1, 2022, 00:00

  • PCR168 The Changing Face of Qualitative Interviewing in Clinical Outcome Assessments Research: Conducting Qualitative Interviews Post COVID-19

    Dec 1, 2022, 00:00

  • EE408 Economic Evaluation of Endovascular Therapy for Acute Stroke With a Large Ischemic Region in China

    Dec 1, 2022, 00:00

  • HTA137 Evidence Review Group Criticism of Clinical Effectiveness Systematic Reviews in NICE Oncology Submissions

    Dec 1, 2022, 00:00

  • SA28 Unique Device Identifiers for Cardiac Implantable Electronic Devices – A Data Quality Assessment of Administrative Hospital Data in Portugal

    Dec 1, 2022, 00:00

  • HSD94 A Novel Method to Measure Health

    Dec 1, 2022, 00:00

  • CO81 A Bayesian Approach to Increase Evidence of Effectiveness in Health Economic Evaluations of Treatments for Rare Diseases

    Dec 1, 2022, 00:00

  • A Scoping Review of the Use of Machine Learning in Health Economics and Outcomes Research: Part 2—Data From Nonwearables [Editor's Choice]

    Dec 1, 2022, 00:00

  • RWD91 The Burden of Fall by Cause and Injury Type in Older Populations and Its Impact on Healthcare Utilization in the US

    Dec 1, 2022, 00:00

  • EPH107 Treatment Landscape for Patients With Advanced Systemic Mastocytosis in Germany in 2015 to 2020 Based on Claims Data Analysis

    Dec 1, 2022, 00:00

  • EE133 Budget Impact Related to Complications on Post-Bariatric Surgery Patients in Brazilian Public Healthcare System

    Dec 1, 2022, 00:00

  • EPH46 Three-Year Epidemiology, Economic Burden and All-Cause Mortality Among Palmoplantar Pustolosis Patients: A Canadian Incidence Study of Inpatient Care, Emergency Departments, and Hospital- or Community-Based Outpatient Clinics

    Dec 1, 2022, 00:00

  • EE667 The Opportunity of High-Dose Vaccination Against Influenza for Adults Aged 60 and Above in the Netherlands

    Dec 1, 2022, 00:00

  • RWD164 The Impact of the COVID-19 Pandemic on Patients With Type 2 Diabetes in Gree Results From a Real-World Study

    Dec 1, 2022, 00:00

  • MSR31 Evidence Synthesis for Decision-Making: Is Meta-Analysis Always Required?

    Dec 1, 2022, 00:00

  • OP3 Experience in Assessing Students’ Knowledge on TBL Methodology

    Dec 1, 2022, 00:00

  • MT39 Factors Influencing the Uptake of Magnetic Resonance Imaging-Guided High Intensity Focused Ultrasound for Painful Bone Metastases in Europe: A Group Concept Mapping Study

    Dec 1, 2022, 00:00

  • EE151 Health Utilities Associated With Sacituzumab Govitecan (SG) for Treating Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer (MTNBC)

    Dec 1, 2022, 00:00

  • PCR237 Effect of Eptinezumab on Utility Scores in Patients With Migraine: Results From the Deliver Study

    Dec 1, 2022, 00:00

  • EE626 Analysis of Healthcare Resource Use of the Robotic Surgery System for Lung Cancer in Japan

    Dec 1, 2022, 00:00

  • Meeting

    Dec 1, 2022, 00:00

  • PCR242 Understanding the Real-World Experience of People With Haemophilia A Receiving Turoctocog Alfa Pegol (N8-GP): Results From a Patient Experience Survey

    Dec 1, 2022, 00:00

  • HTA16 Purchasing Implantable Medical Devices in Egypt Using a Multicriteria Decision Analysis (MCDA) Tool

    Dec 1, 2022, 00:00

  • RWD156 Long- and Short-Acting Methylphenidate Consumption in South Africa

    Dec 1, 2022, 00:00

  • EE505 Systematic Literature Review of Economic Evaluations for 1L Treatment of Advanced/Metastatic NSCLC in the EU5

    Dec 1, 2022, 00:00

  • OP14 Racial and Ethnic Minority Inclusion in Clinical Outcome Assessment (COA) Research: A Reflection on Current Practices

    Dec 1, 2022, 00:00

  • HTA99 NICE Evaluations of Oncology Products With EMA Conditional Marketing Authorisation

    Dec 1, 2022, 00:00

  • EE475 Observational, Retrospective Study on the Evaluation of Direct and Indirect Costs Generated by Multiple Myeloma (MM) in Algeria

    Dec 1, 2022, 00:00

  • PCR170 Mapping IWQOL-Lite Onto EQ-5D-5L and SF-6DV2 in Chinese Overweight and Obese Population

    Dec 1, 2022, 00:00

  • HPR144 TNF-Alfa Inhibitor Biosimilars: Qualitative Analysis of Uptake Determinants in Southern European Hospital Markets

    Dec 1, 2022, 00:00

  • HPR19 Tax Revenue Gains and Societal Net-Monetary Benefit Associated With Implementing Lung Cancer Screening in the United Kingdom

    Dec 1, 2022, 00:00

  • RWD43 Early Symptom-Change Contributes to the Outcome Prediction of Cognitive Behavioral Therapy for Depression Patients: A Machine Learning Approach

    Dec 1, 2022, 00:00

  • EE164 Cost-Effectiveness of Neuromuscular Electrical Stimulation for the Treatment of Mild Obstructive Sleep Apnea: An Exploratory Analysis

    Dec 1, 2022, 00:00

  • MSR46 A Bayesian Hierarchical Modelling Approach for Indirect Comparison of Response Outcomes in Histology-Independent Therapies

    Dec 1, 2022, 00:00

  • P26 Disinvestment Impact, Processes, Policies and Experiences Worldwide: A Systematic Review

    Dec 1, 2022, 00:00

  • HSD46 Human Resources Costs in Breast Cancer Biopsy Processing in Chile: What's the Impact of Human Resources?

    Dec 1, 2022, 00:00

  • PCR110 International X-Linked Hypophosphataemia (XLH) Registry: Capturing Patient-Reported Outcome Data

    Dec 1, 2022, 00:00

  • Exploring the Impact of Cancer Treatment on Patients' Quality of Life

    Dec 1, 2022, 00:00

  • EE621 Cost of Illness of Vaccine-Preventable Diseases in France

    Dec 1, 2022, 00:00

  • P2 The Value of Vaccination: Capturing the Impact of Vaccination on Health Equity in Health Economic Analysis

    Dec 1, 2022, 00:00

  • HTA270 Use of Patient Preference Studies to Support HTA Submissions in Oncology

    Dec 1, 2022, 00:00

  • HSD43 COPD Patients Receiving Fixed or Open-Label Triple Therapy: Initiation and Persistence of Treatment Based on Data From a Real-World Ambulatory Medicalized Database in France

    Dec 1, 2022, 00:00

  • EE335 Cost-Efectiveness Analysis Between Multichambered Standarized Pediatric Parental Nutrition and Individualized Compounded Parental Nutrition, Analysis From the Mexican Public Health System Perspective

    Dec 1, 2022, 00:00

  • MSR141 Building Bridges: What Pandemic Preparedness Can Learn From Real-Option Value Analyses of Water Infrastructure in the Netherlands

    Dec 1, 2022, 00:00

  • EE193 Lorlatinib as a First-Line Treatment for ALK+ Advanced Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis in Spain

    Dec 1, 2022, 00:00

  • PCR15 Throat Pain and Discomfort Associated With Transesophageal Echocardiography in Chinese Atrial Fibrillation Patients With Planned Radio-Frequency Ablation: A Patient Survey Study

    Dec 1, 2022, 00:00

  • CO8 Ponatinib vs Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia: A Matching Adjusted Indirect Comparison

    Dec 1, 2022, 00:00

  • PCR191 Classification of Functioning, Disability Health: Validity of Preference-Weighted Scores

    Dec 1, 2022, 00:00

  • HTA72 Examining the Effectiveness of the Cancer Drugs Fund: Are Data Collection Plans Working as Intended?

    Dec 1, 2022, 00:00

  • CO18 Exploring Endpoint Correlation Between Progression Free Survival (PFS) and Overall Survival (OS) in Previously Untreated Metastatic Melanoma Using Pseudo Individual Patient Data (IPD)

    Dec 1, 2022, 00:00

  • EE633 A Targeted Literature Review of the Modelling Approaches and Challenges in Early-Stage Oncology Treatment Sequence Models

    Dec 1, 2022, 00:00

  • PCR97 Patient and Caregiver Insight Into the Impact of Non-Muscle Invasive Bladder Cancer and Its Treatments: A Social Media Review

    Dec 1, 2022, 00:00

  • PCR140 Higher Need for Medical and Societal Resources of Moderately-to-Severely Affected Myasthenia Gravis Patients in Comparison to the General Population: Analysis of Digitally Collected Observational Data From 8 Countries

    Dec 1, 2022, 00:00

  • MSR143 How Uncertain Is Uncertainty Testing in Budget Impact Models?

    Dec 1, 2022, 00:00

  • EE67 Cost Per Responder and Number Needed to Treat of iGlarlixi vs Premix BIAsp 30 in Algerian Setting

    Dec 1, 2022, 00:00

  • HPR210 Future BeNeLuxA Success – A Partnership vs a Prescription Model

    Dec 1, 2022, 00:00

  • EE184 Assessing the Cost-Effectiveness of the Novavax COVID-19 Vaccine as a Potential Booster Vaccine Option for Adults in the United States

    Dec 1, 2022, 00:00

  • EPH193 Assessment of Diuretic Drug Consumption in Ukraine

    Dec 1, 2022, 00:00

  • Paying for Kidneys: Reflections on Welfare Economics, Political Economy, and Market Design

    Dec 1, 2022, 00:00

  • PCR246 Patient Preferences Regarding Thrombopoietin-Receptor Agonists for Immune Thrombocytopenia in Italy (TRAPeze Italy Study)

    Dec 1, 2022, 00:00

  • MT29 Advantages of 3D Visualization Systems for Teaching in Ophthalmology

    Dec 1, 2022, 00:00

  • EE623 Cost-Minimization Analysis of a High Concentration Adalimumab Biosimilar: The Greek Context

    Dec 1, 2022, 00:00

  • HPR197 Designing a Performance-Based Risk Sharing Arrangement for Aducanumab

    Dec 1, 2022, 00:00

  • SA70 Survey of Sport-Specific Lower Limb Injuries in 15 of Hungary's Most Popular Sports

    Dec 1, 2022, 00:00

  • HSD7 Analysis of the Balanced Scorecard's Knowledge and Growth Subdimensions in Health Care Organizations During the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • MSR94 An Exploration of How Influential Digitisation Approaches Are in Their Impact on Survival Estimates for Health Technology Assessment (HTA)

    Dec 1, 2022, 00:00

  • HTA151 The NICE Cost Comparison Pathway - How Much Evidence Is Required to Meet the Criteria?

    Dec 1, 2022, 00:00

  • HTA22 ITC Appraisal by French HTA Committees: Comprehensive Review and Comparison

    Dec 1, 2022, 00:00

  • EE11 Burden of Myelodysplastic Syndromes Part II: Systematic Literature Review of Economic Burden

    Dec 1, 2022, 00:00

  • HTA142 Potential Impact of Biomarker Guided-Decisions on Overtreatment in Immunotherapy for Non-Small Cell Lung Cancer Patients

    Dec 1, 2022, 00:00

  • MT44 Extent of Use of Artificial Intelligence and Machine Learning Protocols in Cancer Diagnosis: A Scoping Review

    Dec 1, 2022, 00:00

  • RWD19 Real-World Disease Burden of Chronic Obstructive Pulmonary Disease: A Retrospective Population-Based Cohort Study in Tianjin, China

    Dec 1, 2022, 00:00

  • EPH170 Is Hyperammonemic Crisis in Inborn Errors of Metabolism an Ultra-Orphan Disease? A Literature Review

    Dec 1, 2022, 00:00

  • EPH124 Prediction Model to Evaluate the Impact of a Next Generation Bivalent Omicron-Containing COVID-19 Booster (MRNA.1273.214) on Hospitalizations in Adults in Germany

    Dec 1, 2022, 00:00

  • EE622 Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Prevention Interventions in Children: A Model Comparison Study

    Dec 1, 2022, 00:00

  • PCR131 Resilience, and Positive Parenting in Parents of Children With Autism and Intellectual Disability: Evidence From the Impacts of the COVID-19 Pandemic on Family's Quality of Life and Parent-Child Relationships

    Dec 1, 2022, 00:00

  • CO136 Outcomes of Ceramic Versus Metal Heads After Primary Hip Hemiarthroplasty in a National Cohort Up to 10 Years of Follow-up

    Dec 1, 2022, 00:00

  • HPR18 Pharmacoeconomic Evaluation of Orphan Drugs in the United Kingdom, France, Italy, Turkey and Exploration of the Evaluation Process of Orphan Drugs in Algeria

    Dec 1, 2022, 00:00

  • HPR214 Challenges of Measuring Healthcare System Resilience

    Dec 1, 2022, 00:00

  • HTA252 Analyzing Critical Drivers for Success in the Implementation of Outcome-Based Agreements to Manage Clinical Uncertainty Risks in Spain

    Dec 1, 2022, 00:00

  • EPH68 Epidemiological Impact of Generalized SARS-COV-2 Vaccination of Children Aged 5 to 11

    Dec 1, 2022, 00:00

  • EPH120 Clinical and Economic Burden of Severe Pneumococcal Disease Among Adults in Sweden: A Population-Based Register Study

    Dec 1, 2022, 00:00

  • EE359 Real-World Utilization, Treatment Frequency, and Bleeding Outcomes on Damoctocog Alfa Pegol in Haemophilia A Care: Insights From a German Cohort Within the CHESS II Study

    Dec 1, 2022, 00:00

  • EPH49 Nosocomial Infections With Methicillin-Resistant Staphylococcus Aureus (SARM) Potentially Avoided With the Use of Dalbavancin During Hospital Treatment of Acute Bacterial Skin and Skin Structure Infections in Spain

    Dec 1, 2022, 00:00

  • EE458 Modelling Long-Term Clinical Outcomes of Patients with Transfusion-Dependent Beta-Thalassemia in the United States

    Dec 1, 2022, 00:00

  • SA61 Meta-Analysis of Sulodexide and Other Drugs in Prevention and Treatment of Post Thrombotic Syndrome

    Dec 1, 2022, 00:00

  • EE29 Burden of Disease and Cost of Illness of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Bulgaria

    Dec 1, 2022, 00:00

  • EPH138 Understanding the Prevalence and Burden of Diabetic Ketoacidosis (DKA) in People With T1DM at High Risk for DKA: A Structured Literature Review

    Dec 1, 2022, 00:00

  • RWD155 Index Date Validation in OCEANIA a Real-World Database Study – The Importance of Looking Back

    Dec 1, 2022, 00:00

  • HPR109 Medicines Pricing in Bosnia and Herzegovina – What Could Be the Solution to Reduce Prices

    Dec 1, 2022, 00:00

  • RWD157 Challenges and Opportunities of Using Electronic Health Records in Multi-Country Studies

    Dec 1, 2022, 00:00

  • HTA131 An Early Health Technology Assessment of Non-Invasive Fractional Flow Reserve Versus Standard Diagnostics in Patients With Stable Chest Pain in the Netherlands

    Dec 1, 2022, 00:00

  • EE285 Development of a Simulation Model for the Cost-Utility Analysis of Upright Intervention Promoting Resilience in Adolescents

    Dec 1, 2022, 00:00

  • EE469 A Review of Cure Assumptions Implemented in Early-Stage Oncology NICE Appraisals

    Dec 1, 2022, 00:00

  • EE372 Inside CKD – A Projection of Clinical and Economic Burden of Chronic Kidney Disease in Turkey

    Dec 1, 2022, 00:00

  • HTA62 One Size Fit All? The Impact of EUnetHTA Joint Clinical Assessments on National Reimbursement

    Dec 1, 2022, 00:00

  • PCR188 Unearthing Social Determinants of Health From a Patient-Focused Web Platform

    Dec 1, 2022, 00:00

  • EE529 Modeling Studies of Human Papilloma Virus (HPV) Vaccines Cost-Effectiveness and Cervical Cancer Elimination– A Systematic Review

    Dec 1, 2022, 00:00

  • CO131 Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Patients in Finland (FINPAH) – A Descriptive Retrospective Real World Cohort Study Between 2008 and 2020

    Dec 1, 2022, 00:00

  • EPH186 Public Health Impact of Immunotherapies in Advanced Cancers in Fran A National Retrospective Estimate Until End of 2020

    Dec 1, 2022, 00:00

  • EPH73 Diet Quality During the First Two Years of Life and the Women, Infants and Children Program

    Dec 1, 2022, 00:00

  • EE403 Health and Economic Impact of a Novel 3-Antigen Vaccine for the Prevention of Hepatitis B in Adults in Germany: A Cost-Effectiveness Analysis

    Dec 1, 2022, 00:00

  • EE280 Economic Burden of Hyperkalemia in Turkey

    Dec 1, 2022, 00:00

  • PCR276 Difficulties of Elimination Diets - Experiences of Allergy / Intolerance Among Young Adults

    Dec 1, 2022, 00:00

  • HSD11 Evaluation of the Implementation Progress of a New Complex Intervention in a Multimorbidity Patient-Centered Care Model in Chile

    Dec 1, 2022, 00:00

  • EPH162 Pilot Study to Assess the Prevalence of Advanced Gastrointestinal Stromal Tumor Identified Using German Claims Data

    Dec 1, 2022, 00:00

  • PCR288 Understanding Unmet Needs Relating to Unintentional Non-Adherence in Patients With Heart Disease – Review of Existing Evidence to Inform Patient-Centered Interventions

    Dec 1, 2022, 00:00

  • P39 Does the Choice of Modelling Approach Matter When Modelling Stroke Prevention Therapy?

    Dec 1, 2022, 00:00

  • RWD85 Trends in Medicine Utilization and Its Expenditure for Treating Lung Cancer in Catalonia

    Dec 1, 2022, 00:00

  • OP17 Analyzing Health System Resilience From the Perspective of Rare Diseases

    Dec 1, 2022, 00:00

  • CO38 Transdiagnostic Analysis of Mental Disorder Symptoms Associated With Increased Frequency of Psychiatric Hospitalisation

    Dec 1, 2022, 00:00

  • SA40 Outcomes for Patients with Microsatellite Instability-High Metastatic Colorectal Cancer in the Real World Treated with Standard of Care Versus Patients Treated with Nivolumab Plus Low-Dose Ipilimumab in CheckMate 142

    Dec 1, 2022, 00:00

  • EE399 Exploring the Effect of Different Patient Entry Intervals on Budget Impact Estimations

    Dec 1, 2022, 00:00

  • PCR160 Social Support as a Moderator of the Relationship Between Patient Activation, Self-Management of Diabetes, and Diagnosed Diabetes Complications, Among Adults With Type 2 Diabetes

    Dec 1, 2022, 00:00

  • PCR13 Economic Advantages Associated With MS DMTs Mode of Administration

    Dec 1, 2022, 00:00

  • HSD52 Demonstration of the Kitagawa Decomposition to Understand Racial/Ethnic Disparities by Partitioning Within- and Between-Hospital Mean Effects

    Dec 1, 2022, 00:00

  • PCR239 Physician and Patient Preferences for Oral Anticoagulation Therapy Decision-Making in Atrial Fibrillation: Results From a National Best-Worst Scaling Survey in Turkey (PREF-AF)

    Dec 1, 2022, 00:00

  • SA66 Patients' Perspective on Barriers Related to Delayed Diagnosis of Endometriosis: A Systematic Review of Qualitative Studies

    Dec 1, 2022, 00:00

  • SA14 Clinical Evidence on Corticosteroid Treatment Reported in the First Year of the COVID-19 Pandemic – Comparison of Clinical Trial Publications and Treatment Recommendation

    Dec 1, 2022, 00:00

  • PCR217 The Impact of Poor Medication Adherence on Clinical Outcomes and Health Resource Use in Hypertension and/or Dyslipidaemia: A Systematic Literature Review

    Dec 1, 2022, 00:00
  • «
  • 21
  • 22
  • 23 (current)
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • »